These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6175982)

  • 1. Effect of the SQ 14,225 and AQ 20,881 on the kallikrein-kinin system.
    Catanzaro OL; Pola JL; Vila SB; Martinez Seeber A
    Pharmacol Res Commun; 1981 Nov; 13(10):927-35. PubMed ID: 6175982
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of SQ 14225 and SQ 20881 on the norepinephrine contents of the central nervous system.
    Domínguez AE; Fernández BE; Seeber AM
    Arch Int Physiol Biochim; 1981 Feb; 89(1):89-90. PubMed ID: 6166271
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effects of teprotide and captopril.
    Ruddy MC
    Hypertension; 1981; 3(2):277-8. PubMed ID: 6163703
    [No Abstract]   [Full Text] [Related]  

  • 4. Intrarenal kallikrein-kinin activity in acute renovascular hypertension in dogs.
    Verma PS; Gagnon JA; Miller RL
    Ren Physiol; 1988; 10(6):311-7. PubMed ID: 2852835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of SQ 20881 and captopril on mesenteric, renal, and iliac vasculatures.
    Fiksen-Olsen MJ; Britton SL; Houck PC; Romero JC
    Am J Physiol; 1983 Mar; 244(3):H313-9. PubMed ID: 6187226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of specific inhibitors of angiotensin I converting enzyme (kininase II).
    Cushman DW; Cheung HS; Sabo EF; Rubin B; Ondetti MA
    Fed Proc; 1979 Dec; 38(13):2778-82. PubMed ID: 228989
    [No Abstract]   [Full Text] [Related]  

  • 7. Endocrine mechanisms in the pathogenesis of essential hypertension. VI. Blockade of the renin-angiotensin system as a therapeutical basis.
    Păuşescu E
    Physiologie; 1982; 19(4):245-64. PubMed ID: 6185963
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute and chronic effects of captopril on the renin-angiotensin and kallikrein-kinin systems affecting blood pressure and natriuresis.
    Kida O
    Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):343-52. PubMed ID: 3894731
    [No Abstract]   [Full Text] [Related]  

  • 9. Differing effects of two angiotensin converting enzyme inhibitors, captopril and CI-906, on diuresis and the urinary excretion of kallikrein and prostaglandins in spontaneously hypertensive rats.
    Säynävälammi P; Pörsti I; Nurmi AK; Seppälä E; Laitinen LA; Manninen V; Ylitalo P; Vapaatalo H
    Scand J Urol Nephrol Suppl; 1984; 79():23-7. PubMed ID: 6089314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
    Takata Y; Di Nicolantonio R; Hutchinson JS
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kallikrein-kinin system in blood pressure homeostasis.
    Lee TC; Kushiro T; Gassia JP; Girolami JP; Lupu AN; Maxwell MH
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():255s-258s. PubMed ID: 94277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of angiotensin I converting enzyme inhibitor, SQ 14225, on renin production and release.
    Saruta T; Eguchi T; Yasui T; Nagahama S; Nakamura R; Kato E
    Nephron; 1981; 29(5-6):265-9. PubMed ID: 6172718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril and teprotide as discriminators of angiotensin-converting enzyme activity in brain tissue.
    Zubenko GS; Nixon RA
    Neurosci Lett; 1985 Sep; 60(1):33-7. PubMed ID: 2997673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system.
    Kondo K; Kida O; Kodama K; Higa T; Someya N; Morotomi Y; Tanaka K
    Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):337-42. PubMed ID: 2991635
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of angiotensin-converting enzyme inhibitors on the vascular response to norepinephrine.
    Saruta T; Suzuki H; Okuno T; Kondo K
    Am J Cardiol; 1982 Apr; 49(6):1535-6. PubMed ID: 6176110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallikrein-kinin system in one- and two-kidney Goldblatt hypertensive rats.
    Albertini R; Rosas R; Croxatto HR; Roblero J
    Clin Sci (Lond); 1979 Mar; 56(3):227-33. PubMed ID: 477206
    [No Abstract]   [Full Text] [Related]  

  • 17. Responses of the kallikrein-kinin system to angiotensin converting enzyme inhibitors in the rat.
    Yasujima M; Abe K; Tanno M; Omata K; Yoshinaga K
    Jpn Circ J; 1984 Feb; 48(2):173-9. PubMed ID: 6321815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive and renal effects of captopril in spontaneously hypertensive rats: evidence against a role of the kallikrein-kinin system.
    Filep J; Rigter B; Földes-Filep E
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):222-7. PubMed ID: 2441174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal kallikrein-kinin system and the depressor effect of angiotensin converting enzyme inhibitors MK 421, SA 446, and captopril in rats.
    Yasujima M; Abe K; Kasai Y; Tanno M; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K
    Clin Exp Hypertens A; 1984; 6(6):1207-25. PubMed ID: 6086184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SQ 14,225 attenuates the vascular response to norepinephrine in the rat mesenteric arteries.
    Okuno T; Kondo K; Konishi K; Saruta T; Kato E
    Life Sci; 1979 Oct; 25(15):1343-9. PubMed ID: 390286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.